Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sina Darou is a prominent Iranian pharmaceutical company specializing in the production of sterile products, with a primary focus on ophthalmic, nasal, and respiratory treatments. Established in 1962, it has grown to become one of the largest manufacturers of eye drops, gels, and sprays in the Middle East. The company's portfolio includes a vast range of generic medications and specialized formulations across several therapeutic areas, including ophthalmology, otorhinolaryngology, and dermatology. Sina Darou is publicly traded on the Tehran Stock Exchange and operates large-scale manufacturing facilities that adhere to international quality standards to serve both domestic and regional markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sina Darou.